- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial2011 | First Faculty of Medicine
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial2008 | Central Library of Charles University
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial2008 | Faculty of Medicine in Pilsen
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial2008 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Randomised, placebo controlled study of Diacerhein administration in painful osteoarthritis of the kneePublication without faculty affiliation
- Double blind, randomised, placebo controlled, multi-centre study verifying effects of Geladrink Forte prepatations in patients with knee osteoarthritis2008 | First Faculty of Medicine
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials2008 | First Faculty of Medicine
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials2008 | Faculty of Medicine in Pilsen
- Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patiens from two previous 3-year, randomised, placebo-controlled trialsPublication without faculty affiliation
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials2008 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial2018 | Publication without faculty affiliation
- OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy2015 | First Faculty of Medicine
- Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial2011 | Second Faculty of Medicine
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial2019 | Publication without faculty affiliation
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial2019 | Publication without faculty affiliation
- The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury2009 | Third Faculty of Medicine
- Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study2010 | First Faculty of Medicine
- Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial2019 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial2019 | Publication without faculty affiliation
- MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial2018 | Publication without faculty affiliation
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | First Faculty of Medicine
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | Second Faculty of Medicine
- Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial2015 | Faculty of Medicine in Hradec Králové
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial2017 | First Faculty of Medicine
- Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial2004 | Third Faculty of Medicine
- The correlation between ApoEgenotype and clinical and MRI parametrs in relapsing-remitting multiple sclerosis clinical and MRIdata from 2-years double blind, randomised, placebo controled studyPublication without faculty affiliation
- Glucosamine Sulfate Slows-Down Osteoarthritis Progression in Postmenopausal Women: Pooled Analysis of Two Large Independent, Randomised, Placebo-Controlled, Double-Blind, Prospective 3-year Trials +1Publication without faculty affiliation
- Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer2020 | First Faculty of Medicine
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial2023 | First Faculty of Medicine